Efficacy of astragalus polysaccharides (PG2) in alleviating chemotherapy-induced fatigue in gynecologic cancer: a retrospective cohort study
The study concludes that PG2 shows promise as an adjunct therapy in the management of CRF among patients with gynecologic cancer receiving chemotherapy. However, the findings highlight the need for additional prospective, randomized controlled trials to rule out the risk of bias and ascertain PG2's full therapeutic potential in oncology supportive care.
Authors
- Cheng‐Chang Chang (ORCID: https://orcid.org/0000-0002-7356-446X)
- Yi‐Liang Lee (ORCID: https://orcid.org/0000-0002-6723-8131)
- Yi-Hsin Lin (ORCID: https://orcid.org/0000-0002-4408-1784)
- Chia-Ching Chang
- Chih-Hsiang Yin
Institutions
- Tri-Service General Hospital (TW)
- University of Kang Ning (TW)
- National Defense Medical Center (TW)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-07-12
- DOI
- https://doi.org/10.1007/s12672-025-03120-y
- Citations
- 1
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Tri-Service General Hospital